Swiss firm Novartis reveals plans to take over Slovenia's Lek pharmaceutical company, while the battle over the Union brewery goes on.
3 articles read within 30 days
Register for free to read a limited number of articles from the past month.
Find out about premium plans.
Already a member? Please log in here.
Register for free to read more.
Find out about membership plans.
Already a member? Please log in here.
You have reached an article for premium members. To read this article please login if you are already a TOL member. Or continue to read our content from the past month.